Lisata Therapeutics Inc (LSTA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2015 | 06-2015 | 03-2015 | 12-2014 | 09-2014 | |
| Sales | 5,889 | 5,867 | 3,172 | 5,277 | 4,118 |
| Cost of Goods | 4,809 | 5,799 | 3,369 | 4,163 | 4,012 |
| Gross Profit | 1,080 | 68 | -196 | 1,113 | 105 |
| Operating Expenses | 12,272 | 26,536 | 18,260 | 16,829 | 16,376 |
| Operating Income | -10,383 | -25,669 | -18,088 | -15,553 | -16,259 |
| Interest Expense | 553 | 547 | 551 | 372 | 184 |
| Other Income | -410 | 5,355 | -546 | 3,989 | -687 |
| Pre-tax Income | -11,346 | -20,861 | -19,185 | -11,936 | -17,129 |
| Income Tax | 47 | -3,703 | 47 | -246 | 47 |
| Net Income Continuous | -11,393 | -17,158 | -19,232 | -11,690 | -17,177 |
| Minority Interests | -17 | -32 | -45 | -78 | -202 |
| Net Income | $-11,376 | $-17,126 | $-19,187 | $-11,612 | $-16,974 |
| EPS Basic Total Ops | -30.88 | -57.57 | -76.46 | -46.48 | -71.96 |
| EPS Basic Continuous Ops | -30.92 | -57.72 | -76.69 | -46.35 | -73.47 |
| EPS Diluted Total Ops | -30.88 | -57.57 | -76.46 | -46.48 | -71.96 |
| EPS Diluted Continuous Ops | -30.92 | -57.72 | -76.69 | -46.35 | -73.47 |
| EBITDA(a) | $-300 | $-24,986 | $-17,483 | $-14,900 | $-15,661 |